COLL
COLL
NASDAQ · Pharmaceuticals

Collegium Pharmaceutical Inc

$24.21
-0.95 (-3.78%)
As of Nov 7, 10:00 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +98.9% upside
Low Target $33.48
Average Target $48.15
High Target $61.72
Current Price $24.21
Current
$24.21
Target
$48.15
$33.48 $48.15 avg $61.72
Scenario Analysis
Bear Case
$33.48
38.3%
Low target
Base Case
$48.15
+98.9%
Avg target
Bull Case
$61.72
+154.9%
High target
Risk/Reward
4.0x
Highly favorable
Price in Context
52-Week High
$50.79
-52.3% from high
52-Week Low
$21.43
+13.0% from low
Target vs 52W High
$48.15
-5.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%